Skip to main content
Caplight Logo









NeuronUP

NeuronUP

Private
LogroñoHealthcare & Life Scienceshttps://neuronup.com/

Last Round

Private Equity

Jun 17, 2024

Total Funding Raised

$10.71M

Company Overview

NeuronUP is a healthtech company that provides a web-based digital platform for neurorehabilitation and cognitive stimulation for healthcare professionals.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Mental Health, Patient Engagement

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

cognitive rehabilitationcognitive stimulationSaaSneurorehabilitationteletherapyrehabilitation exercisesdigital healthbrain trainingvertical SaaSneuropsychology toolspatient engagementclinical softwareremote patient monitoringhealth techclinical analytics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuronUP Comparables

Compare NeuronUP with similar companies based on industry and business-model similarity.

NeuronUP comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Humans Matter
85%
CogniFit
78%
HASOMED GmbH
77%

NeuronUP Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityJun 17, 2024
AcceleratorSep 1, 2020

Key People

Founding team and executive leadership

Iñigo Fernández de Piérola

CEO

Executive Team

César Ortea Suárez

CTO & Software Architect

Executive Team

Jorge M. Corada

Chief Product Officer, Head of product

Executive Team

NeuronUP Investors

Notable investors and investment history

NeuronUP investors
InvestorRounds
LanzaderaAccelerator
Moira Capital PartnersPrivate Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 21, 2026

    Grew 36% QoQ, from 81 to 110 employees.

  • May 13, 2025

    Grew 19% QoQ, from 83 to 99 employees.

NeuronUP Filings

Explore SEC and related filing metadata, where available.

NeuronUP filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NeuronUP's valuation, stock price, and market status.

Is NeuronUP a public or private company?

NeuronUP is a private company.

What is the current stock price of NeuronUP?

NeuronUP is a private company with no public stock price. No recent secondary market data is available.

How much is NeuronUP worth (valuation)?

Valuation information for NeuronUP is not publicly available.

Can I buy NeuronUP stock?

NeuronUP shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NeuronUP's last funding round?

NeuronUP's most recent funding round was Private Equity on June 17, 2024.

Who are the main investors in NeuronUP?

Key investors in NeuronUP include Lanzadera, Moira Capital Partners.

Will NeuronUP IPO soon?

No public IPO plans have been announced for NeuronUP.

How can I track NeuronUP secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeuronUP's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLogroño
Employee Range87
Year Founded2011
Last FundingJun 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?